Work

EE177 Topical Sirolimus 0.2% Gel for Treatment of Facial Angiofibroma Associated with Tuberous Sclerosis Complex in the United States: A Budget Impact Analysis

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.03.478

Authors: A. Thomas, A.A. Hebert, S. Bhattacharyya, S. Boggarapu, E. Beresford

Institutions: ITC (India), City College, Kolkata, The University of Texas Health Science Center at Houston

Language: English

Topic: Tuberous Sclerosis Complex Research

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4380150012

Cites:

Cited by:

Related to: 10